What Happened?
Richmond, CA-based DiaCarta Promoted Michael Sha as Chief Technology Officer and Senior Vice President of Research & Development
About the Company
DiaCarta is a translational genomics and personalized diagnostics company that provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Our mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world.
About the Person
Michael Sha is Chief Technology Officer and Senior Vice President of Research & Development at DiaCarta. Previously, Michael held various senior IT leadership roles in the industry.
Info Source
News
Short Profile